Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity.

Authors:
FengMing Lan
FengMing Lan
Laboratory of Neuro-Oncology
Qing Qin
Qing Qin
Cancer Center
Ann Arbor | United States
Huiming Yu
Huiming Yu
Shandong University
China
Xiao Yue
Xiao Yue
Tianjin Huanhu Hospital
Tianjin | China

J Neurosurg 2019 Apr 19:1-9. Epub 2019 Apr 19.

4Department of Neurosurgery, The Affiliated Hospital of Xiangnan University, Chenzhou, Hunan, People's Republic of China.

OBJECTIVEAlthough glucose metabolism reengineering is a typical feature of various tumors, including glioma, key regulators of glycolytic reprogramming are still poorly understood. The authors sought to investigate whether glycolysis inhibition by microRNA (miR)-448 increases radiosensitivity in glioma cells.METHODSThe authors used glioma tissue samples from glioma patients, cells from glioblastoma (GBM) cell lines and normal human astrocyte cells, and subcutaneous tumor-bearing U87 cells in mice to examine the effects of signaling regulation by miR-448 in the response of glioma tissues and cells to radiation treatment. Techniques used for investigation included bioinformatics analyses, biochemical assays, luciferase reporter assays, and establishment of subcutaneous tumors in a mouse model. Glucose consumption, LDH activity, and cellular ATP were measured to determine the ability of glioma cells to perform glycolysis. Expression of HIF-1α was measured as a potential target gene of miR-448 in glycolysis.RESULTSmiR-448 was detected and determined to be significantly downregulated in both glioma tissues from glioma patients and GBM cell lines. Furthermore, miR-448 acted as a tumor-inhibiting factor and suppressed glycolysis in glioma by negatively regulating the activity of HIF-1α signaling and then interfering with its downstream regulators relative to glycolysis, HK1, HK2, and LDHA. Interestingly, overexpression of miR-448 increased the x-radiation sensitivity of glioma cells. Finally, in in vivo experiments, subcutaneous tumor-bearing U87 cells in a mouse model verified that high expression of miR-448 also enhanced glioma radiosensitivity via inhibiting glycolytic factors.CONCLUSIONSmiR-448 can promote radiosensitivity by inhibiting HIF-1α signaling and then negatively controlling the glycolysis process in glioma. A newly identified miR-448-HIF-1α axis acts as a potentially valuable therapeutic target that may be useful in overcoming radioresistance in glioma treatment.

Download full-text PDF

Source
https://thejns.org/view/journals/j-neurosurg/aop/article-10.
Publisher Site
http://dx.doi.org/10.3171/2018.12.JNS181798DOI Listing
April 2019
3 Reads

Publication Analysis

Top Keywords

glioma
14
mouse model
8
radiosensitivity inhibiting
8
gbm cell
8
glioma tissues
8
cell lines
8
glioma cells
8
subcutaneous tumor-bearing
8
hif-1α signaling
8
glioma patients
8
glycolysis inhibition
8
tumor-bearing u87
8
glioma radiosensitivity
8
u87 cells
8
mir-448
7
cells
7
glycolysis
6
gene mir-448
4
mir-448 glycolysisresultsmir-448
4
measured potential
4

Similar Publications